Recent advances in nanoengineering cellulose for cargo delivery.

Bacterial cellulose Cancer therapy Cellulose nanocrystals Cellulose nanofibrils Drug delivery Hairy nanocellulose Nanocellulose Wound healing

Journal

Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908

Informations de publication

Date de publication:
28 01 2019
Historique:
received: 28 06 2018
revised: 16 11 2018
accepted: 25 11 2018
pubmed: 1 12 2018
medline: 21 3 2020
entrez: 1 12 2018
Statut: ppublish

Résumé

The recent decade has witnessed a growing demand to substitute synthetic materials with naturally-derived platforms for minimizing their undesirable footprints in biomedicine, environment, and ecosystems. Among the natural materials, cellulose, the most abundant biopolymer in the world with key properties, such as biocompatibility, biorenewability, and sustainability has drawn significant attention. The hierarchical structure of cellulose fibers, one of the main constituents of plant cell walls, has been nanoengineered and broken down to nanoscale building blocks, providing an infrastructure for nanomedicine. Microorganisms, such as certain types of bacteria, are another source of nanocelluloses known as bacterial nanocellulose (BNC), which benefit from high purity and crystallinity. Chemical and mechanical treatments of cellulose fibrils made up of alternating crystalline and amorphous regions have yielded cellulose nanocrystals (CNC), hairy CNC (HCNC), and cellulose nanofibrils (CNF) with dimensions spanning from a few nanometers up to several microns. Cellulose nanocrystals and nanofibrils may readily bind drugs, proteins, and nanoparticles through physical interactions or be chemically modified to covalently accommodate cargos. Engineering surface properties, such as chemical functionality, charge, area, crystallinity, and hydrophilicity, plays a pivotal role in controlling the cargo loading/releasing capacity and rate, stability, toxicity, immunogenicity, and biodegradation of nanocellulose-based delivery platforms. This review provides insights into the recent advances in nanoengineering cellulose crystals and fibrils to develop vehicles, encompassing colloidal nanoparticles, hydrogels, aerogels, films, coatings, capsules, and membranes, for the delivery of a broad range of bioactive cargos, such as chemotherapeutic drugs, anti-inflammatory agents, antibacterial compounds, and probiotics. SYNOPSIS: Engineering certain types of microorganisms as well as the hierarchical structure of cellulose fibers, one of the main building blocks of plant cell walls, has yielded unique families of cellulose-based nanomaterials, which have leveraged the effective delivery of bioactive molecules.

Identifiants

pubmed: 30500355
pii: S0168-3659(18)30685-0
doi: 10.1016/j.jconrel.2018.11.024
pmc: PMC6385607
mid: NIHMS1516613
pii:
doi:

Substances chimiques

Cellulose 9004-34-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-76

Subventions

Organisme : NCI NIH HHS
ID : U01 CA214411
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB023052
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR066193
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR057837
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB024403
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB021857
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL137193
Pays : United States
Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Références

Biomacromolecules. 2007 Aug;8(8):2485-91
pubmed: 17630692
J Tissue Eng Regen Med. 2017 Dec;11(12):3544-3555
pubmed: 28326684
J Drug Target. 2019 Mar;27(3):229-243
pubmed: 29415575
Nanotechnology. 2013 Feb 22;24(7):075103
pubmed: 23358497
J Photochem Photobiol B. 2017 Oct;175:83-88
pubmed: 28865318
Int J Nanomedicine. 2011;6:321-30
pubmed: 21383857
Int J Nanomedicine. 2017 Mar 14;12:2021-2031
pubmed: 28352172
ACS Biomater Sci Eng. 2017 Aug 14;3(8):1666-1676
pubmed: 33429649
ACS Appl Mater Interfaces. 2015 Feb 4;7(4):2607-15
pubmed: 25562313
J Pharm Pharmacol. 2017 Nov;69(11):1477-1484
pubmed: 28809440
Crit Rev Biotechnol. 2017 Jun;37(4):510-524
pubmed: 27248159
Int J Biol Macromol. 2018 Oct 15;118(Pt A):640-648
pubmed: 29894784
Langmuir. 2018 May 15;34(19):5464-5473
pubmed: 29715039
Chem Soc Rev. 2018 Apr 23;47(8):2609-2679
pubmed: 29658545
Chem Rev. 2010 Jun 9;110(6):3479-500
pubmed: 20201500
Biomacromolecules. 2017 Apr 10;18(4):1401-1410
pubmed: 28323423
Int J Pharm. 2012 Oct 1;435(1):83-7
pubmed: 22266531
Int J Nanomedicine. 2012;7:5577-91
pubmed: 23144561
Carbohydr Polym. 2018 Jun 1;189:379-398
pubmed: 29580422
J Phys Chem B. 2015 May 7;119(18):5911-7
pubmed: 25885570
Biotechnol Res Int. 2012;2012:976203
pubmed: 23304525
Macromol Biosci. 2017 Nov;17(11):
pubmed: 28941135
Int J Biol Macromol. 2017 Sep;102:1166-1173
pubmed: 28487196
Chem Soc Rev. 2011 Jul;40(7):3941-94
pubmed: 21566801
Carbohydr Polym. 2017 Oct 15;174:580-590
pubmed: 28821108
Nanomaterials (Basel). 2017 Mar 05;7(3):
pubmed: 28336891
Int J Pharm. 2017 Nov 25;533(1):285-297
pubmed: 28951349
J Nanobiotechnology. 2016 Dec 1;14(1):78
pubmed: 27903280
Biotechnol Rep (Amst). 2017 Jul 06;15:84-91
pubmed: 28736723
Nat Rev Chem. 2017 Aug;1(8):
pubmed: 31286060
Nanomicro Lett. 2015;7(3):219-242
pubmed: 30464967
Carbohydr Polym. 2017 May 15;164:258-267
pubmed: 28325325
J Colloid Interface Sci. 2018 Jan 1;509:39-46
pubmed: 28881204
Nat Rev Cancer. 2017 Nov;17(11):659-675
pubmed: 29026204
J Agric Food Chem. 2018 Jan 10;66(1):339-345
pubmed: 29224351
J Control Release. 2017 Jul 28;258:226-253
pubmed: 28472638
Cell Adh Migr. 2018;12(6):529-537
pubmed: 29168660
Langmuir. 2012 Dec 11;28(49):17124-33
pubmed: 23146090
Clin Appl Thromb Hemost. 2018 May;24(4):566-574
pubmed: 29363998
Angew Chem Int Ed Engl. 2011 Jun 6;50(24):5438-66
pubmed: 21598362
ACS Appl Mater Interfaces. 2014 Feb 12;6(3):1709-18
pubmed: 24387200
Chem Soc Rev. 2017 Jan 3;46(1):158-196
pubmed: 27841412
Evid Based Complement Alternat Med. 2004 Dec;1(3):251-257
pubmed: 15841258
Acta Biomater. 2018 Jul 15;75:346-357
pubmed: 29885527
Biomacromolecules. 2005 Mar-Apr;6(2):1048-54
pubmed: 15762677
Langmuir. 2017 Jun 6;33(22):5473-5481
pubmed: 28494586
Nat Rev Mater. 2016 Dec;1(12):
pubmed: 29657852
Acta Biomater. 2018 Mar 15;69:196-205
pubmed: 29341931
Chem Soc Rev. 2017 Oct 30;46(21):6600-6620
pubmed: 28828455
Langmuir. 2012 May 22;28(20):7834-42
pubmed: 22482733
Nat Rev Mol Cell Biol. 2005 Nov;6(11):850-61
pubmed: 16261190
IUBMB Life. 2005 Dec;57(12):787-96
pubmed: 16393781
Carbohydr Polym. 2017 May 15;164:214-221
pubmed: 28325319
Nano Rev Exp. 2018 Jul 03;9(1):1488497
pubmed: 30410712
Nanoscale. 2014 Jul 21;6(14):7764-79
pubmed: 24937092
Adv Mater. 2018 Jun;30(24):e1703779
pubmed: 29504161
Prog Polym Sci. 2017 Aug;71:53-90
pubmed: 32287485
Biomacromolecules. 2018 Jan 8;19(1):150-157
pubmed: 29182312
Carbohydr Polym. 2017 Dec 15;178:270-276
pubmed: 29050594
Int J Nanomedicine. 2013;8:3255-69
pubmed: 24023514
Chempluschem. 2016 Jun;81(6):504-514
pubmed: 31968918
Nanoscale. 2012 Jun 7;4(11):3274-94
pubmed: 22565323
Biomacromolecules. 2017 Dec 11;18(12):4405-4410
pubmed: 29135235
Int J Biol Macromol. 2017 Nov;104(Pt A):97-106
pubmed: 28587970
ACS Appl Mater Interfaces. 2017 Feb 15;9(6):5477-5485
pubmed: 28102068
Ther Deliv. 2017 Aug;8(9):753-761
pubmed: 28825390
Curr Opin Chem Eng. 2015 Feb;7:84-92
pubmed: 25621200
Int J Pharm. 2014 Jan 30;461(1-2):74-81
pubmed: 24291076
Biomacromolecules. 2011 Nov 14;12(11):4162-8
pubmed: 21999108
Biomaterials. 2017 Apr;122:34-47
pubmed: 28107663
Sci Technol Adv Mater. 2017 Nov 23;18(1):959-971
pubmed: 29383046
J Pharm Pharmacol. 2014 Aug;66(8):1047-61
pubmed: 24628270
ACS Appl Mater Interfaces. 2018 Feb 14;10(6):5862-5870
pubmed: 29345902
J Am Chem Soc. 2018 Mar 28;140(12):4244-4252
pubmed: 29504396
Carbohydr Polym. 2014 Jun 15;106:410-3
pubmed: 24721096
Carbohydr Polym. 2014 Jan;99:649-65
pubmed: 24274556
Carbohydr Polym. 2017 Jan 2;155:425-431
pubmed: 27702531
Eur J Pharm Biopharm. 2014 Apr;86(3):332-6
pubmed: 23973717
Soft Matter. 2017 May 31;13(21):3936-3945
pubmed: 28504291
Carbohydr Polym. 2017 Feb 10;157:1013-1023
pubmed: 27987801
Carbohydr Polym. 2016 Oct 5;150:216-26
pubmed: 27312632
Carbohydr Polym. 2018 Sep 1;195:63-70
pubmed: 29805020
Sci Rep. 2017 Dec 21;7(1):18031
pubmed: 29269741
Biomacromolecules. 2014 May 12;15(5):1560-7
pubmed: 24716601
Biochem Soc Trans. 2017 Feb 8;45(1):229-236
pubmed: 28202677
Int J Biol Macromol. 2017 Aug;101:165-171
pubmed: 28322949
ACS Nano. 2018 Jul 24;12(7):6469-6479
pubmed: 29874029
Technol Cancer Res Treat. 2015 Dec;14(6):757-66
pubmed: 24750004
Eur J Pharm Biopharm. 2017 Mar;112:164-176
pubmed: 27889415
Drug Discov Today. 2018 Apr;23(4):912-919
pubmed: 29499377
J Mater Chem B. 2013 Jun 21;1(23):2976-2984
pubmed: 32260865
Spectrochim Acta A Mol Biomol Spectrosc. 2018 Jan 5;188:675-683
pubmed: 28526195
Inhal Toxicol. 2002 Jul;14(7):685-703
pubmed: 12122570
Carbohydr Polym. 2018 Jan 1;179:126-134
pubmed: 29111035
Eur J Pharm Biopharm. 2018 Jun;127:130-141
pubmed: 29462687
Dan Med Bull. 1990 Feb;37(1):57-84
pubmed: 2155760
Drug Deliv Transl Res. 2019 Apr;9(2):444-452
pubmed: 29302918
Carbohydr Polym. 2013 Apr 15;94(1):154-69
pubmed: 23544524
Nanotechnol Sci Appl. 2015 Nov 04;8:45-54
pubmed: 26604715
J Control Release. 2017 Jul 28;258:81-94
pubmed: 28483514
ACS Appl Mater Interfaces. 2010 Oct;2(10):2924-32
pubmed: 20919683
Polymers (Basel). 2017 Feb 15;9(2):
pubmed: 30970742
Curr Med Chem. 2017;24(5):512-528
pubmed: 27758719
Nanomaterials (Basel). 2018 Apr 08;8(4):
pubmed: 29642486
Adv Colloid Interface Sci. 2017 Aug;246:13-39
pubmed: 28716187
Pharmacol Rev. 1981 Mar;33(1):17-53
pubmed: 7027277
Int J Pharm. 2012 Jul 1;430(1-2):47-55
pubmed: 22465549
Curr Pharm Des. 2017;23(35):5213-5229
pubmed: 28552068
Carbohydr Polym. 2018 Jan 15;180:286-296
pubmed: 29103507
Carbohydr Polym. 2017 Aug 1;169:357-365
pubmed: 28504156
Carbohydr Polym. 2018 Jan 15;180:246-255
pubmed: 29103503
Biomacromolecules. 2011 May 9;12(5):1585-93
pubmed: 21438518
Nanoscale. 2015 Oct 28;7(40):16647-57
pubmed: 26154822
ACS Appl Mater Interfaces. 2013 Apr 24;5(8):2999-3009
pubmed: 23521616
Appl Microbiol Biotechnol. 2016 Mar;100(5):2063-72
pubmed: 26743657
Eur J Pharm Biopharm. 2012 Oct;82(2):308-15
pubmed: 22750440
Expert Opin Drug Deliv. 2010 Aug;7(8):915-25
pubmed: 20586704
Expert Opin Drug Deliv. 2014 Oct;11(10):1661-80
pubmed: 25054316
Int J Biol Macromol. 2018 May;111:604-613
pubmed: 29325745
Part Fibre Toxicol. 2017 Jan 10;14(1):1
pubmed: 28069023
Langmuir. 2017 Sep 26;33(38):9772-9780
pubmed: 28853581
J Colloid Interface Sci. 2018 Sep 1;525:119-125
pubmed: 29689416
Biomacromolecules. 2014 May 12;15(5):1852-9
pubmed: 24716647
Adv Drug Deliv Rev. 2018 Apr;129:95-117
pubmed: 29627369
J Mater Sci Mater Med. 2015 Oct;26(10):245
pubmed: 26411441
Carbohydr Polym. 2018 Jan 1;179:186-195
pubmed: 29111041
Nanoscale. 2016 Aug 18;8(33):15101-14
pubmed: 27453347
Adv Ther. 2017 Mar;34(3):599-610
pubmed: 28108895
J Mater Chem B. 2015 Feb 28;3(8):1688-1698
pubmed: 32262441
Adv Drug Deliv Rev. 2018 Mar 15;128:84-100
pubmed: 29567396
J Control Release. 2016 Dec 28;244(Pt A):74-82
pubmed: 27847327
Biomacromolecules. 2009 Sep 14;10(9):2571-6
pubmed: 19645441
Nano Today. 2017 Oct;16:82-96
pubmed: 31186671
Carbohydr Polym. 2017 Jun 1;165:322-333
pubmed: 28363556
Carbohydr Polym. 2014 Jan;99:47-58
pubmed: 24274478
J Control Release. 2011 Dec 20;156(3):390-7
pubmed: 21802462
Biomacromolecules. 2008 Jan;9(1):57-65
pubmed: 18052127
Adv Healthc Mater. 2018 Mar;7(6):e1701024
pubmed: 29210522
Expert Opin Emerg Drugs. 2015 Jun;20(2):235-46
pubmed: 25704608
Int J Pharm. 2014 Aug 25;471(1-2):45-55
pubmed: 24792978
Nat Commun. 2018 Jan 9;9(1):2
pubmed: 29317618
ACS Appl Mater Interfaces. 2014 May 14;6(9):6127-38
pubmed: 24746103
Tissue Eng Part A. 2017 Jul;23(13-14):597-608
pubmed: 28384029
Int J Biol Macromol. 2017 Nov;104(Pt A):748-757
pubmed: 28629862
Chem Rev. 2016 Aug 24;116(16):9305-74
pubmed: 27459699
Biotechnol Prog. 2018 Mar;34(2):537-545
pubmed: 29314760
J Control Release. 2014 Mar 10;177:51-63
pubmed: 24394377
Biol Pharm Bull. 2002 Jun;25(6):695-704
pubmed: 12081132
Carbohydr Polym. 2018 May 15;188:27-36
pubmed: 29525166
Adv Mater. 2018 May 7;:e1705328
pubmed: 29736981
Environ Sci Technol. 2015 May 5;49(9):5277-87
pubmed: 25837659
Adv Drug Deliv Rev. 2018 Jan 1;123:3-17
pubmed: 28941987
Biomacromolecules. 2017 Jun 12;18(6):1803-1813
pubmed: 28436646
J Agric Food Chem. 2018 Jan 31;66(4):935-942
pubmed: 29283261
Carbohydr Polym. 2014 Jan;99:140-9
pubmed: 24274490
Chem Soc Rev. 2014 Mar 7;43(5):1519-42
pubmed: 24316693
Prog Mater Sci. 2017 Aug;89:392-410
pubmed: 29129946
Toxicol Rep. 2017 Sep 25;4:543-553
pubmed: 29090119
Biomacromolecules. 2018 Feb 12;19(2):544-554
pubmed: 29334612

Auteurs

Amir Sheikhi (A)

Department of Bioengineering, University of California - Los Angeles, 410 Westwood Plaza, Los Angeles, CA 90095, USA; Center for Minimally Invasive Therapeutics (C-MIT), California NanoSystems Institute (CNSI), University of California - Los Angeles, 570 Westwood Plaza, Los Angeles, CA 90095, USA.

Joel Hayashi (J)

Department of Bioengineering, University of California - Los Angeles, 410 Westwood Plaza, Los Angeles, CA 90095, USA; Center for Minimally Invasive Therapeutics (C-MIT), California NanoSystems Institute (CNSI), University of California - Los Angeles, 570 Westwood Plaza, Los Angeles, CA 90095, USA.

James Eichenbaum (J)

Department of Bioengineering, University of California - Los Angeles, 410 Westwood Plaza, Los Angeles, CA 90095, USA; Center for Minimally Invasive Therapeutics (C-MIT), California NanoSystems Institute (CNSI), University of California - Los Angeles, 570 Westwood Plaza, Los Angeles, CA 90095, USA.

Mark Gutin (M)

Department of Bioengineering, University of California - Los Angeles, 410 Westwood Plaza, Los Angeles, CA 90095, USA; Center for Minimally Invasive Therapeutics (C-MIT), California NanoSystems Institute (CNSI), University of California - Los Angeles, 570 Westwood Plaza, Los Angeles, CA 90095, USA.

Nicole Kuntjoro (N)

Department of Bioengineering, University of California - Los Angeles, 410 Westwood Plaza, Los Angeles, CA 90095, USA; Center for Minimally Invasive Therapeutics (C-MIT), California NanoSystems Institute (CNSI), University of California - Los Angeles, 570 Westwood Plaza, Los Angeles, CA 90095, USA.

Danial Khorsandi (D)

Department of Bioengineering, University of California - Los Angeles, 410 Westwood Plaza, Los Angeles, CA 90095, USA; Center for Minimally Invasive Therapeutics (C-MIT), California NanoSystems Institute (CNSI), University of California - Los Angeles, 570 Westwood Plaza, Los Angeles, CA 90095, USA.

Ali Khademhosseini (A)

Department of Bioengineering, University of California - Los Angeles, 410 Westwood Plaza, Los Angeles, CA 90095, USA; Center for Minimally Invasive Therapeutics (C-MIT), California NanoSystems Institute (CNSI), University of California - Los Angeles, 570 Westwood Plaza, Los Angeles, CA 90095, USA; Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095, USA; Department of Chemical and Biomolecular Engineering, University of California - Los Angeles, 5531 Boelter Hall, Los Angeles, CA 90095, USA; Department of Bioindustrial Technologies, College of Animal Bioscience and Technology, Konkuk University, Seoul 143-701, Republic of Korea. Electronic address: khademh@ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH